Part of what makes Johns Hopkins’ Montgomery County Campus unique is the mix of academics, corporate entities, research centers, and non-profit organizations. Current partners include:

Blanchette Rockefeller Neurosciences Institute

• Seeks to accelerate neurological discoveries from the lab directly to patients suffering from neurological diseases such as Alzheimer’s.

CATO Research

• Helps pharmaceutical and biotechnology companies bring products to market by designing and implementing nonclinical, regulatory, product development, manufacturing and clinical strategies for drugs, biologics, and medical devices.

CBH Health

• Offers comprehensive behavioral health services to the Baltimore and Washington metro area and specializes in Central Nervous System Disorders.
• Executes phase I through IV clinical research.

CellOptic, Inc.

• This spin-out company from a Hopkins researcher seeks to advance 3-D imaging technology

Chiesi Pharmaceuticals

• Focuses on the development of innovative pharmaceutical products for the management of various pulmonary disorders.

Federation of Families for Children’s Mental Health

• National Headquarters for more than 125 family-driven organizations dedicated exclusively to helping children with mental health needs and their families achieve a better quality of life.

Johns Hopkins University Microscopy Center

• Houses advanced and specialized light and fluorescence microscopic facilities and services which play an important role in research and discovery.
• Makes state-of-the-art equipment available to the greater Washington area biotech, research, and government communities.

Sekorts

• This spin-out company from a Hopkins researcher discovers and develops drugs to prevent stroke-induced brain damage.

TissueGene

• Develps regenerative medicine therapeutics for degenerative disorders including osteoarthritic diseases and degenerative joint diseases.
• Developed a proprietary cell technology with applications in the treatment and regeneration of damaged tissues such as cartilage and bones .

Vanda Pharmaceuticals

• Designs therapeutic treatments to manage drug development with greater productivity and to deliver model products that significantly improve patient health.
• Targets schizophrenia, bipolar disorder, and stress disorders.